Akèy › Metiyè › Chemists › Malvern, PA
Chemists nan Malvern, PA: Salè H-1B
27 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Malvern, PA. Salè baz medyàn ofri $93,750; mwatye mitan $76,346–$112,437.
Demann (LCA)27
Salè medyan ofri$93,750
Mwatye salè yo$76,346–$112,437
10yèm–90yèm pousantaj$67,400–$122,000
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $70,786 |
| Nivo II (kalifye) | $81,734 |
| Nivo III (eksperyans) | $110,210 |
| Nivo IV (plen kompetans) | $125,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 8 | $74,246 |
| Flamma USA LLC | 7 | $110,420 |
| Alliance Pharma, Inc. | 2 | $106,875 |
| Venatorx Pharmaceuticals, Inc. | 2 | $115,337 |
| Seven Star Pharmaceutical Services LLC | 2 | $67,000 |
| Janssen Research & Development, LLC | 2 | $145,000 |
| FMC Corporation | 1 | $82,514 |
| PPD Development, L.P. | 1 | $100,000 |
| Resolian Inc. | 1 | $91,933 |
| Eurofins Professional Scientific Services Mid-Atlantic, LLC. | 1 | $80,954 |
Tit travay
- Characterization Scientist2
- Research Scientist2
- Senior Scientist I2
- Scientist III Group Leader2
- Analytical Separations Scientist2
- Project Lead1
- Global Regulatory Compliance Specialist1
- Senior Analytical Scientist1
- Senior Scientist1
- Chemist1
- Process Scientist III1
- Senior Formulation Scientist1
- Associate Research Scientist1
- Scientist II, Analytical Development1
- Scientist, Downstream Process/Antibody-Drug Conjugation1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).